跳至主要内容
临床试验/JPRN-UMIN000017350
JPRN-UMIN000017350已完成未知

The evaluation for safety and efficacy of combination therapy of adoptive immune-cell therapy with chemoradiotherapy for locally advanced esophageal cancer - The evaluation for safety and efficacy of combination therapy of adoptive immune-cell therapy with chemoradiotherapy for locally advanced esophageal cancer

Gunma University0 个研究点目标入组 6 人开始时间: 2015年4月30日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Patient with interstitial pneumonia (2) Patient who received cancer immunotherapy (3) Patient with active autoimmune disease (4) Patient with active heart disease (5) Patient with uncontrollable infectious diseases (6) Patient with serious drug allergy (7) Patient with uncontrollable diabetes mellitus (8) Patient with active multiple malignancies (9) Patient with continuous use of systemic administration of steroids (10) Patient with severe psychological disorders (11) Patient in pregnancy (12) Patient positive for HIV or HTLV-1 (13) Current participation in other drug clinical trials. (excluding the study, which doesn't need intervention) (14) Patients who are inadequate to enter this study due to the other reasons by physician's judgments

研究者

相似试验